Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.

Dios A, Mitchell RA, Aljabari B, Lubetsky J, O'Connor K, Liao H, Senter PD, Manogue KR, Lolis E, Metz C, Bucala R, Callaway DJ, Al-Abed Y.

J Med Chem. 2002 Jun 6;45(12):2410-6.

PMID:
12036350
2.

Characterization of a novel hemoglobin-glutathione adduct that is elevated in diabetic patients.

Al-Abed Y, VanPatten S, Li H, Lawson JA, FitzGerald GA, Manogue KR, Bucala R.

Mol Med. 2001 Sep;7(9):619-23.

3.

HMG-1 as a late mediator of endotoxin lethality in mice.

Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ.

Science. 1999 Jul 9;285(5425):248-51.

5.

HIV results in the frame. Other approaches.

Bukrinsky M, Manogue K, Cerami A.

Nature. 1995 May 18;375(6528):195-6; author reply 198. No abstract available.

PMID:
7746316
6.

Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.

Dubrovsky L, Ulrich P, Nuovo GJ, Manogue KR, Cerami A, Bukrinsky M.

Mol Med. 1995 Jan;1(2):217-30.

7.

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.

Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA, Fuh H, Manogue KR, et al.

Lancet. 1994 Jun 18;343(8912):1519-22.

PMID:
7911868
8.

Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766-70.

9.

MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R.

Nature. 1993 Oct 21;365(6448):756-9. Erratum in: Nature 1995 Nov 23;378(6555):419.

PMID:
8413654
10.
12.

Macrophage inflammatory proteins 1 and 2: an overview.

Sherry B, Horii Y, Manogue KR, Widmer U, Cerami A.

Cytokines. 1992;4:117-30. Review. No abstract available.

PMID:
1472913
13.

Human decidua: a source of cachectin-tumor necrosis factor.

Romero R, Mazor M, Manogue K, Oyarzun E, Cerami A.

Eur J Obstet Gynecol Reprod Biol. 1991 Sep 13;41(2):123-7.

PMID:
1936492
14.

Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78.

Widmer U, Yang Z, van Deventer S, Manogue KR, Sherry B, Cerami A.

J Immunol. 1991 Jun 1;146(11):4031-40.

PMID:
2033269
15.

The role of cachectin/TNF and other cytokines in sepsis.

Zentella A, Manogue K, Cerami A.

Prog Clin Biol Res. 1991;367:9-24. Review.

PMID:
1924435
17.

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM.

Lancet. 1990 Nov 17;336(8725):1201-4.

PMID:
1978068
18.

Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages.

Jue DM, Sherry B, Luedke C, Manogue KR, Cerami A.

Biochemistry. 1990 Sep 11;29(36):8371-7.

PMID:
2252898
19.

Monocyte function in IDDM patients and healthy individuals.

Mølvig J, Pociot F, Baek L, Worsaae H, Dall Wogensen L, Christensen P, Staub-Nielsen L, Mandrup-Poulsen T, Manogue K, Nerup J.

Scand J Immunol. 1990 Sep;32(3):297-311.

PMID:
1698309
20.
21.

Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality.

Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shires GT, et al.

Surg Gynecol Obstet. 1990 Jan;170(1):32-8.

PMID:
2294627
22.

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, et al.

J Exp Med. 1989 Nov 1;170(5):1627-33.

23.

Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture.

Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM.

Clin Exp Immunol. 1989 Sep;77(3):361-6.

24.

Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor.

Romero R, Manogue KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, Cerami A.

Am J Obstet Gynecol. 1989 Aug;161(2):336-41.

PMID:
2764054
25.

Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.

Fong Y, Moldawer LL, Marano M, Wei H, Barber A, Manogue K, Tracey KJ, Kuo G, Fischman DA, Cerami A, et al.

Am J Physiol. 1989 Mar;256(3 Pt 2):R659-65.

PMID:
2784290
26.

Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo.

Moldawer LL, Marano MA, Wei H, Fong Y, Silen ML, Kuo G, Manogue KR, Vlassara H, Cohen H, Cerami A, et al.

FASEB J. 1989 Mar;3(5):1637-43.

PMID:
2784116
27.

Interleukin-2 initiates metabolic responses associated with critical illness in humans.

Michie HR, Eberlein TJ, Spriggs DR, Manogue KR, Cerami A, Wilmore DW.

Ann Surg. 1988 Oct;208(4):493-503.

28.

Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings.

Michie HR, Spriggs DR, Manogue KR, Sherman ML, Revhaug A, O'Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolff SM, et al.

Surgery. 1988 Aug;104(2):280-6.

PMID:
2456628
29.

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.

Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A.

Science. 1988 Jun 10;240(4858):1546-8.

PMID:
3259727
30.

Detection of circulating tumor necrosis factor after endotoxin administration.

Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW.

N Engl J Med. 1988 Jun 9;318(23):1481-6.

PMID:
2835680
31.

Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences.

Mølvig J, Baek L, Christensen P, Manogue KR, Vlassara H, Platz P, Nielsen LS, Svejgaard A, Nerup J.

Scand J Immunol. 1988 Jun;27(6):705-16.

PMID:
3260683
32.

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, et al.

J Exp Med. 1988 Mar 1;167(3):1211-27.

33.

Cytokine appearance in human endotoxemia and primate bacteremia.

Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA Jr, Cerami A, Shires GT, Lowry SF.

Surg Gynecol Obstet. 1988 Feb;166(2):147-53.

PMID:
3122336
34.
35.

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A.

Nature. 1987 Dec 17-23;330(6149):662-4.

PMID:
3317066
36.

Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Tracey KJ, Lowry SF, Fahey TJ 3rd, Albert JD, Fong Y, Hesse D, Beutler B, Manogue KR, Calvano S, Wei H, et al.

Surg Gynecol Obstet. 1987 May;164(5):415-22.

PMID:
3576418
37.

Bilateral interactions within the vocal control pathway of birds: two evolutionary alternatives.

Paton JA, Manogue KR.

J Comp Neurol. 1982 Dec 20;212(4):329-35. No abstract available.

PMID:
7161412
38.

Respiratory gating of activity in the avian vocal control system.

Manogue KR, Paton JA.

Brain Res. 1982 Sep 16;247(2):383-7. No abstract available.

PMID:
7127135
39.
40.

Bilateral organization of the vocal control pathway in the budgerigar, Melopsittacus undulatus.

Paton JA, Manogue KR, Nottebohm F.

J Neurosci. 1981 Nov;1(11):1279-88.

41.

Selective brain stem transections affecting reproductive behavior of female rats: the role of hypothalamic output to the midbrain.

Manogue KR, Kow LM, Pfaff DW.

Horm Behav. 1980 Dec;14(4):277-302. No abstract available.

PMID:
7216184

Supplemental Content

Loading ...
Support Center